Literature DB >> 1833393

Identification of the functional domains of the transcriptional regulator CRE-BP1.

S Matsuda1, T Maekawa, S Ishii.   

Abstract

We present evidence that CRE-BP1 binding to the cyclic AMP (cAMP) response element (CRE) is a transcriptional activator. Transcriptional activation was assayed by cotransfection into CV-1 cells of a CRE-BP1 expression plasmid together with a reporter plasmid in which the thymidine kinase promoter and four tandem repeats of CRE were linked to the chloramphenicol acetyltransferase (CAT) gene. Cotransfection with the CRE-BP1 expression plasmid caused an 8-fold stimulation of CAT activity, while cotransfection with the plasmids to express CRE-BP1 and c-Jun induced a 32-fold stimulation of CAT activity, suggesting that a heterodimer of CRE-BP1 with c-Jun is a stronger trans-activator than a homodimer of CRE-BP1. By using a series of deletion and point mutants of CRE-BP1 in this cotransfection assay, two functional domains of CRE-BP1 were identified: the putative metal finger structure in the amino-terminal region and the leucine zipper motif linked to a cluster of basic amino acids in the carboxyl-terminal region. The former was a transcriptional activation domain in the absence of c-Jun. The latter was a DNA-binding domain, and was essential in both the presence and absence of c-Jun.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833393

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.

Authors:  N Aoyama; T Nagase; T Sawazaki; G Mizuguchi; H Nakagoshi; J I Fujisawa; M Yoshida; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Transcription of the human transferrin gene in neuronal cells.

Authors:  B E Sawaya; E Schaeffer
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

3.  Reduced levels of ATF-2 predispose mice to mammary tumors.

Authors:  Toshio Maekawa; Toshie Shinagawa; Yuji Sano; Takahiko Sakuma; Shintaro Nomura; Koichi Nagasaki; Yoshio Miki; Fumiko Saito-Ohara; Johji Inazawa; Takashi Kohno; Jun Yokota; Shunsuke Ishii
Journal:  Mol Cell Biol       Date:  2006-12-22       Impact factor: 4.272

4.  Drosophila activating transcription factor-2 is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase.

Authors:  Yuji Sano; Hiroshi Akimaru; Tomoo Okamura; Tomoko Nagao; Masahiro Okada; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-03-23       Impact factor: 4.138

5.  Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter.

Authors:  A Bruhat; C Jousse; V Carraro; A M Reimold; M Ferrara; P Fafournoux
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  The CR1 and CR3 domains of the adenovirus type 5 E1A proteins can independently mediate activation of ATF-2.

Authors:  M C Duyndam; H van Dam; A J van der Eb; A Zantema
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

7.  Different binding specificities and transactivation of variant CRE's by CREB complexes.

Authors:  D M Benbrook; N C Jones
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

8.  The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors.

Authors:  Toshio Maekawa; Wanzhu Jin; Shunsuke Ishii
Journal:  Mol Cell Biol       Date:  2009-11-30       Impact factor: 4.272

9.  Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.

Authors:  Balasubramanyam Karanam; Ling Wang; Dongxia Wang; Xin Liu; Ronen Marmorstein; Robert Cotter; Philip A Cole
Journal:  Biochemistry       Date:  2007-06-23       Impact factor: 3.162

10.  Conversion of G-protein specificity of insulin-like growth factor II/mannose 6-phosphate receptor by exchanging of a short region with beta-adrenergic receptor.

Authors:  K Takahashi; Y Murayama; T Okamoto; T Yokota; T Ikezu; S Takahashi; U Giambarella; E Ogata; I Nishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.